Angus Cloud, the actor known for portraying fan-favorite drug dealer Fezco in HBO’s 'Euphoria', died of an accidental overdose

Israel's Prime Minister Benjamin Netanyahu on Monday urged Elon Musk to fight anti-Semitism on his X platform as he sat down with the tech...

The Detroit Red Wings might finally have enough talent to end a seven-year postseason drought, which matches their longest in franchise history

John McGinn said the “big moments went against Scotland” and made victory in Spain “near enough impossible” as Steve Clarke’s side missed out on the chance to secure early qualification for Euro 2024 following a controversial 2-0 defeat in Seville. Scotland needed a point against Spain to book their place at the Euros next summer and, although they had to survive spells of pressure against the hosts, thought they had made the breakthrough when Scott McTominay scored a sublime free-kick on 59 minutes. But McTominay’s goal was disallowed by referee Serdar Gozubuyuk after a VAR check, with the initial explanation being that Scotland defender Jack Hendry had infringed on Spain goalkeeper Unai Simon. However, McGinn said the Dutch official then clarified that Hendry was offside and was interfering with play. Spain took the lead moments later through Alvaro Morata and although Scotland will still qualify if Norway fail to beat La Roja in Oslo on Sunday, the visitors were left to rue some significant blows. Scotland also lost captain Andy Robertson to a dislocated shoulder before half time. Scotland were aiming to become the first team to take a point off Spain in home Euro qualifiers since 2003, a run that is now 25 matches ago, and McGinn said: “The big moments went against us. We can still improve, but we put in some shift. “We knew at least a point tonight would get us there, so that’s a really tough one to take. It’s a sore blow losing Robbo early, then thinking we’re ahead, we regroup and then they score. “We competed for long spells. It’s very difficult to win here and, under the circumstances, it was near enough impossible. “You need to be very careful what you say. I think everyone watching that game tonight from a Scotland point of view, wherever you were, it just felt like we weren’t getting any 50/50 decision - it made it very difficult against a world class team. “You need a perfect performance here to win, and everything to align and it was just never going to happen. “He (the referee) changed it (his reasoning on the VAR check) in the game, which is the annoying thing. It means it’s not clear and obvious. “Is he going to save it? No chance. No goalkeeper in the world is going to save that. However, at one point he’s said it’s a foul, realises it isn’t a foul, so changes it to offside.” Scotland manager Clarke meanwhile said his players have to move on after the defeat. Clarke’s men face France in a friendly in Lille next Tuesday but Spain face Norway in Oslo two days earlier and if the Norwegians drop points, Scotland’s place in Germany will be secured. The Scots also have Georgia away and Norway at home in November. “The team played well and the players are disappointed,” said Clarke. “We came here determined to qualify. It hasn’t happened tonight but I think there was a lot to be pleased about in the performance. “The big moment in the game is probably the close decision on the Scott McTominay goal. At the time we think it is a goal. You know when the referee gets told to look at it he is probably going to chalk it off. They have made the call, there is no point me going on about it.” Includes reporting from PA Read More Scotland forced to wait for Euro 2024 — but they will not understand how Steve Clarke insists Scotland must move on from disappointing VAR decision Andy Robertson injury: Scotland provide update on dislocated shoulder against Spain Scotland provide update after Andy Robertson appears to dislocate shoulder Steve Clarke insists Scotland must move on from disappointing VAR decision Scotland forced to wait for Euro 2024 – but they will not understand how

An assessment of Jude Bellingham's La Liga debut for Real Madrid against Athletic Club as he joined the likes of Laurie Cunningham, David Beckham and Michael Owen as Englishman to score for Los Blancos

TIANJIN, China China's economic growth in the second quarter will be higher than the first and was projected

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’

BASEL, Switzerland--(BUSINESS WIRE)--Sep 5, 2023--

Bola Tinubu, 71, won February's election with a promise to renew hope and needs to act fast.

The Pittsburgh Steelers are flying high after Sunday's win over the Ravens. T.J. Watt is hurt (but still playing), a RB battle is brewing, and a WR is back.

Exxon Mobil Corp. plans to begin producing lithium in Arkansas, marking an entry into the provision of a

The Brooklyn Nets are reportedly looking to trade wings Royce O'Neale and Dorian Finney-Smith for first-round picks. Can they actually do it?In the wake of the midseason Kevin Durant trade, the Brooklyn Nets reportedly aren't done trying to make moves this offseason.According to ES...